Literature DB >> 6275903

Evidence for selective regulation of the phosphorylation of myocyte proteins by isoproterenol and prostaglandin E1.

J S Hayes, N Bowling, K L King, G B Boder.   

Abstract

Both isoproterenol and prostaglandin E1 increased the activation state of cyclic AMP-dependent protein kinase in cultured myocytes; however, only isoproterenol enhanced phosphorylase activity and contractile state. Following the incubation of intact myocytes with 32PO3-(4), 32 phosphoproteins were resolved from total cellular proteins by electrophoresis in sodium dodecyl sulfate polyacrylamide gels followed by autoradiography. Isoproterenol stimulated 32PO3-(4) incorporation into 16 proteins, including 2 phosphoproteins not observed under control conditions. By contrast, prostaglandin E1 neither caused a measurable change in the protein phosphorylation pattern nor interfered with isoproterenol's capacity to do so. Isoproterenol stimulated myocyte protein phosphorylation in either the presence or absence of extracellular Ca2+. The results suggest that the regulation of protein phosphorylation following adenylate cyclase stimulation is: (1) an agonist-specific process and not due solely to a random accumulation of intracellular cycle AMP and activation of protein kinase; (2) the Ca2+ mobilization component of beta-receptor activation does not account for the paradoxical effects of isoproterenol and prostaglandin E1; (3) activation of cyclic AMP-dependent protein kinase does not always result in an enhancement of protein phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6275903     DOI: 10.1016/0304-4165(82)90135-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

Review 1.  Role of soluble adenylyl cyclase in the heart.

Authors:  Jonathan Chen; Lonny R Levin; Jochen Buck
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

Review 2.  Molecular details of cAMP generation in mammalian cells: a tale of two systems.

Authors:  Margarita Kamenetsky; Sabine Middelhaufe; Erin M Bank; Lonny R Levin; Jochen Buck; Clemens Steegborn
Journal:  J Mol Biol       Date:  2006-07-28       Impact factor: 5.469

Review 3.  Protein phosphorylation and compartments of cyclic AMP in the control of cardiac contraction.

Authors:  K J Murray; M L Reeves; P J England
Journal:  Mol Cell Biochem       Date:  1989-09-07       Impact factor: 3.396

4.  Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum.

Authors:  Y Shakur; M Wilson; L Pooley; M Lobban; S L Griffiths; A M Campbell; J Beattie; C Daly; M D Houslay
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

Review 5.  The adenylyl cyclase family.

Authors:  J Krupinski
Journal:  Mol Cell Biochem       Date:  1991 May 29-Jun 12       Impact factor: 3.396

Review 6.  Phosphodiesterase inhibition in heart failure.

Authors:  Matthew Movsesian; Josef Stehlik; Fabrice Vandeput; Michael R Bristow
Journal:  Heart Fail Rev       Date:  2008-12-19       Impact factor: 4.214

7.  Inotropic actions of eicosanoids.

Authors:  K Schrör; T Hohlfeld
Journal:  Basic Res Cardiol       Date:  1992 Jan-Feb       Impact factor: 17.165

Review 8.  cAMP and mitochondria.

Authors:  Federica Valsecchi; Lavoisier S Ramos-Espiritu; Jochen Buck; Lonny R Levin; Giovanni Manfredi
Journal:  Physiology (Bethesda)       Date:  2013-05

Review 9.  Phosphodiesterases and Compartmentation of cAMP and cGMP Signaling in Regulation of Cardiac Contractility in Normal and Failing Hearts.

Authors:  Gaia Calamera; Lise Román Moltzau; Finn Olav Levy; Kjetil Wessel Andressen
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 5.923

Review 10.  PTH1R Actions on Bone Using the cAMP/Protein Kinase A Pathway.

Authors:  T John Martin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-19       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.